Follow us...


Search News Archives

News Channels


Coronavirus (COVID-19)


View Channel

New Laboratory Products


View Channel

Lab News


View Channel

Research & Case Studies


View Channel

Microscopy | Image Analysis


View Channel

Separation Science


View Channel



View Channel

Events | Webinars


View Channel

Conferences | Events

PRIORCLAVE renew their partnership with BioCote

Linda McKeaveney, BioCote’s Customer Relations Manager, and Priorclave’s MD Tony Collins, seal a partnership  for a further two years. Priorclave Ltd. manufacture quality autoclaves and offer solutions to the more complex problems of effective sterilisation, in particular, applications synonymous with laboratory requirements. 

Priorclave Ltd. and BioCote Ltd have had a long-standing, exclusive agreement to incorporate the revolutionary BioCote® powder coating technology into the manufacture of their entire range of laboratory autoclaves.  As a result, such has been the success of the combined technologies, they have renewed their partnership for a further two years. 

The silver based, BioCote®coating technology incorporated into the exterior surfaces of the Priorclaves aids the fight against cross-infection by inhibiting the growth of a wide range of micro-organisms, including bacteria  such as E-Coli, Pseudomonas and the superbug MRSA within hospital, biochemical and pharmaceutical laboratory environments as well as food industry, research sectors and many others.   

Since the launch of BioCote® the reduced risk of cross-infection and cross-contamination has been dramatic and has been proven to work through many environmental studies across many disciplines, the most recent of which has been undertaken within the nursing home sector.  

A refurbished care home in Leicester was kitted out with a bedroom and ensuite containing BioCote® protected products and compared to similar untreated products in another refitted bedroom and ensuite. The combined average reduction in microbe levels was an astonishing 94.6% fewer on the BioCote® treated surfaces, similar to that seen at the trial conducted at the outpatients clinics within the Heart of England NHS Foundation Trust, where BioCote® treated surfaces demonstrated an overall average of 95.8% reduction.   Together, both of these studies have been published in the Journal of Infection Prevention and the British Journal of Community Nursing. 

No less vital is the maintenance of the hygiene standards within a busy working laboratory where the Priorclave surface will be touched, inevitably, by operatives handling organisms during normal shared use of the equipment and is, therefore, likely to be an area where cross-contamination might be an issue.   

Typical sterilisation applications cover media preparation, glassware and instruments, and waste disposal.  All are critical in the maintenance of good hygiene practice and sterile working conditions.  In this arena Priorclave continue to have a unique range of autoclaves with the capacity to inhibit the growth of bacteria, not only on the inside - but also on the outside. 

This technology however, should be regarded as an enhancement to, and not a replacement for, good cleaning and sterilisation practice. 

For full details of the Priorclave range of Laboratory Autoclaves please visit their website:


If you have not logged into the website then please enter your details below.



Popular this Month...

Our Top 10 most popular articles this month


Today's Picks...




Looking for a Supplier?

Search by company or by product


Company Name:




Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd




Media Partners